150 related articles for article (PubMed ID: 27726016)
41. The history of the use of radioactive iodine.
Beierwaltes WH
Semin Nucl Med; 1979 Jul; 9(3):151-5. PubMed ID: 388622
[No Abstract] [Full Text] [Related]
42. ATA Guidelines: do patients with stage I thyroid cancer benefit from (131)I?
McDougall IR; Hay ID
Thyroid; 2007 Jun; 17(6):595-6; author reply 596-7. PubMed ID: 17614785
[No Abstract] [Full Text] [Related]
43. Northern Cancer Network guidelines for management of thyroid cancer.
Regional Thyroid Cancer Group
Clin Oncol (R Coll Radiol); 2000; 12(6):373-91. PubMed ID: 11202091
[No Abstract] [Full Text] [Related]
44. [The basis for radioiodine therapy in differentiated thyroid cancer].
Haldemann AR
Ther Umsch; 1999 Jul; 56(7):403-7. PubMed ID: 10434780
[TBL] [Abstract][Full Text] [Related]
45. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
[TBL] [Abstract][Full Text] [Related]
46. Radioiodine therapy of thyroid autonomy.
Reiners C; Schneider P
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
[TBL] [Abstract][Full Text] [Related]
47. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
Jeon MJ; Kim WG; Park WR; Han JM; Kim TY; Song DE; Chung KW; Ryu JS; Hong SJ; Shong YK; Kim WB
Eur J Endocrinol; 2014 Jan; 170(1):23-30. PubMed ID: 24088549
[TBL] [Abstract][Full Text] [Related]
48. Meta-analysis on Successful Ablation After Low- Versus High-Dose Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma.
Zakavi SR
Clin Nucl Med; 2016 Aug; 41(8):674. PubMed ID: 26914569
[No Abstract] [Full Text] [Related]
49. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
50. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
51. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.
Goffredo P; Thomas SM; Dinan MA; Perkins JM; Roman SA; Sosa JA
JAMA Intern Med; 2015 Apr; 175(4):638-40. PubMed ID: 25686394
[No Abstract] [Full Text] [Related]
52. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
[TBL] [Abstract][Full Text] [Related]
53. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
54. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
55. Do we read carefully?
Medvedec M
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
[No Abstract] [Full Text] [Related]
56. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
57. State of the art of therapy in nuclear medicine.
Becker W
Rev Esp Med Nucl; 2000 Oct; 19(6):437-51. PubMed ID: 11060275
[No Abstract] [Full Text] [Related]
58. Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making.
Tuttle RM; Sabra MM
Oral Oncol; 2013 Jul; 49(7):676-83. PubMed ID: 23601564
[TBL] [Abstract][Full Text] [Related]
59. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
60. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
Padma S; Sundaram PS
J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]